181 related articles for article (PubMed ID: 28736021)
1. Infectious Complications and Multidrug-Resistant Bacteria in Patients With Hematopoietic Stem Cell Transplantation in the First 12 Months After Transplant.
César-Arce A; Volkow-Fernández P; Valero-Saldaña LM; Acosta-Maldonado B; Vilar-Compte D; Cornejo-Juárez P
Transplant Proc; 2017; 49(6):1444-1448. PubMed ID: 28736021
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
3. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
4. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study.
Styczynski J; Czyzewski K; Wysocki M; Gryniewicz-Kwiatkowska O; Kolodziejczyk-Gietka A; Salamonowicz M; Hutnik L; Zajac-Spychala O; Zaucha-Prazmo A; Chelmecka-Wiktorczyk L; Siewiera K; Fraczkiewicz J; Malas Z; Tomaszewska R; Irga-Jaworska N; Plonowski M; Ociepa T; Pierlejewski F; Gamrot Z; Urbanek-Dadela A; Gozdzik J; Stolpa W; Dembowska-Baginska B; Perek D; Matysiak M; Wachowiak J; Kowalczyk J; Balwierz W; Kalwak K; Chybicka A; Badowska W; Szczepanski T; Drozynska E; Krawczuk-Rybak M; Urasinski T; Mlynarski W; Woszczyk M; Karolczyk G; Sobol-Milejska G; Gil L;
Clin Microbiol Infect; 2016 Feb; 22(2):179.e1-179.e10. PubMed ID: 26493843
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
7. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
9. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology of early infections after autologous hematopoietic stem cell transplantation.
Lakatos B; Szabó H; Csordás K; Tatai G; Nikolova R; Csomor J; Reményi P; Masszi T; Vályi-Nagy I; Sinkó J
Orv Hetil; 2020 Jan; 161(3):103-109. PubMed ID: 31928060
[TBL] [Abstract][Full Text] [Related]
11. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome.
Mendes ET; Dulley F; Basso M; Batista MV; Coracin F; Guimarães T; Shikanai-Yasuda MA; Levin AS; Costa SF
Int J Infect Dis; 2012 Jun; 16(6):e424-8. PubMed ID: 22463920
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
Satlin MJ; Walsh TJ
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Infectious Complications in Children With Acute Lymphoblastic Leukemia Treated With Hematopoietic Stem Cell Transplantation.
Zaucha-Prażmo A; Kowalczyk JR; Drabko K; Czyżewski K; Goździk J; Zając-Spychała O; Wachowiak J; Frączkiewicz J; Gorczyńska E; Kałwak K; Styczyński J
Transplant Proc; 2017 Nov; 49(9):2183-2187. PubMed ID: 29149980
[TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study.
Scheich S; Reinheimer C; Brandt C; Wichelhaus TA; Hogardt M; Kempf VAJ; Brunnberg U; Brandts C; Ballo O; von Metzler I; Kessel J; Serve H; Steffen B
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1455-1462. PubMed ID: 28528711
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: characteristics and risk factors for infectious complications.
Stoma I; Karpov I; Krivenko S; Iskrov I; Milanovich N; Koritko A; Uss A
Ann Hematol; 2018 May; 97(5):885-891. PubMed ID: 29380038
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant bacterial infections in children undergoing haematopoietic stem cell transplantation over a 6-year period: analysis of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Wiącek P; Zaucha-Prażmo A; Kowalczyk JR; Goździk J; Styczyński J
J Appl Microbiol; 2020 Jan; 128(1):292-300. PubMed ID: 31529556
[TBL] [Abstract][Full Text] [Related]
17. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
18. Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group.
Waszczuk-Gajda A; Drozd-Sokołowska J; Basak GW; Piekarska A; Mensah-Glanowska P; Sadowska-Klasa A; Wierzbowska A; Rzepecki P; Tomaszewska A; Mańko J; Hus M; Adamska M; Romejko-Jarosińska J; Dybko J; Biernat M; Kyrcz-Krzemień S; Sędzimirska M; Winciorek N; Jędrzejczak WW; Styczyński J; Giebel S; Gil L
Transplant Proc; 2020 Sep; 52(7):2178-2185. PubMed ID: 32217016
[TBL] [Abstract][Full Text] [Related]
19. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
Barlas T; İnci K; Aygencel G; Türkoğlu M; Tunçcan ÖG; Can F; Aydın Kaynar L; Özkurt ZN; Yeğin ZA; Yağcı M
Hematology; 2021 Dec; 26(1):328-339. PubMed ID: 33818297
[TBL] [Abstract][Full Text] [Related]
20. Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation.
Orasch C; Weisser M; Mertz D; Conen A; Heim D; Christen S; Gratwohl A; Battegay M; Widmer A; Flückiger U
Bone Marrow Transplant; 2010 Mar; 45(3):521-6. PubMed ID: 19668238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
